跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Kefpoxime - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Kefpoxime
Approved
STANDARD
Kefpoxime
Scott-Edil Advance Research Laboratories & Education Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7dac652db358adcb
Company
Scott-Edil Advance Research Laboratories & Education Ltd.
Type
Standard
Approval Details
Approval Id
7dac652db358adcb
Drug Approval Philippines Name
Kefpoxime
Product Name
Kefpoxime
Registration Number
DR-XY44887
Brand Name
Kefpoxime
Generic Name
Cefpodoxime (As Proxetil)
Dosage Form
Powder For Suspension
Dosage Strength
100mg/5mL
Manufacturer
Scott-Edil Advance Research Laboratories & Education Ltd.
Importer
I.E. Medica, Inc.
Distributor
Alkem Laboratories Corporation
Issuance Date
24 June 2020
Expiry Date
04 December 2025
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7dac652db358adcb
Type
Standard
Back to Philippines FDA Approvals